Stem (NYSE:STEM) Given New $2.50 Price Target at UBS Group

Stem (NYSE:STEMFree Report) had its price objective reduced by UBS Group from $5.00 to $2.50 in a report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock.

STEM has been the topic of several other reports. Evercore ISI dropped their price objective on Stem from $13.00 to $9.00 and set an outperform rating on the stock in a report on Friday, May 3rd. BMO Capital Markets dropped their target price on shares of Stem from $2.50 to $1.85 and set a market perform rating on the stock in a research report on Friday, May 3rd. Piper Sandler reduced their target price on Stem from $3.00 to $2.00 and set a neutral rating for the company in a report on Thursday, April 11th. Susquehanna dropped their price target on Stem from $5.50 to $4.00 and set a positive rating for the company in a research report on Thursday, February 29th. Finally, The Goldman Sachs Group reduced their price objective on Stem from $2.50 to $2.00 and set a neutral rating for the company in a research note on Monday. One research analyst has rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of Hold and an average target price of $4.77.

Check Out Our Latest Stock Report on STEM

Stem Stock Performance

NYSE STEM opened at $1.37 on Wednesday. The firm has a market capitalization of $215.36 million, a P/E ratio of -0.94 and a beta of 1.91. The stock has a 50-day simple moving average of $1.90 and a two-hundred day simple moving average of $2.78. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.78 and a current ratio of 1.88. Stem has a fifty-two week low of $1.27 and a fifty-two week high of $7.79.

Stem (NYSE:STEMGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.25). The company had revenue of $25.50 million during the quarter, compared to analyst estimates of $66.67 million. Stem had a negative net margin of 40.03% and a negative return on equity of 34.37%. The company’s revenue was down 61.9% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.29) earnings per share. On average, equities analysts forecast that Stem will post -0.51 earnings per share for the current year.

Insider Activity

In related news, COO Michael James Carlson sold 9,952 shares of Stem stock in a transaction on Friday, February 16th. The stock was sold at an average price of $3.17, for a total value of $31,547.84. Following the completion of the transaction, the chief operating officer now directly owns 20,367 shares in the company, valued at $64,563.39. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Stem news, COO Michael James Carlson sold 9,952 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $3.17, for a total transaction of $31,547.84. Following the completion of the transaction, the chief operating officer now owns 20,367 shares in the company, valued at approximately $64,563.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CRO Alan Russo sold 14,390 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $3.17, for a total transaction of $45,616.30. Following the completion of the sale, the executive now directly owns 158,204 shares in the company, valued at $501,506.68. The disclosure for this sale can be found here. Over the last three months, insiders have purchased 130,418 shares of company stock worth $238,045 and have sold 772,268 shares worth $1,650,229. Insiders own 10.17% of the company’s stock.

Institutional Trading of Stem

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. abrdn plc purchased a new position in shares of Stem in the 4th quarter valued at about $40,000. Neuberger Berman Group LLC purchased a new position in Stem in the fourth quarter valued at approximately $41,000. Sequoia Financial Advisors LLC acquired a new stake in Stem during the third quarter worth approximately $55,000. Horizon Family Wealth Inc. purchased a new stake in shares of Stem during the 3rd quarter worth approximately $57,000. Finally, Wellington Wealth Strategies LLC. acquired a new position in shares of Stem in the 4th quarter valued at $66,000. 61.63% of the stock is currently owned by institutional investors and hedge funds.

Stem Company Profile

(Get Free Report)

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

See Also

Analyst Recommendations for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.